Topics and Expertise: CERSI

School of Pharmacy leads in NIH funding for the 44th straight year

School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

Dozens of presumed inactive ingredients may impact human biology

School scientists identify excipients with potential to cause side effects

FDA, academia, and industry join forces to shepherd new therapies to patients

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

Update from the Dean - March 2017

Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication...